BIOPEOPLE
Jim Anthony appointed as CCO & President of Parexel Biotech
Parexel, a leading global clinical research organization( CRO) has appointed Jim Anthony to the expanded role of Chief Commercial Officer( CCO) and President, Parexel Biotech, further strengthening the company’ s customer focus and its ability to drive growth and value. Anthony has served as the global leader for Parexel Biotech since its inception in 2019, and most recently as President and Global Head, Parexel Biotech.
Qure. ai appoints Dr Javier J Zulueta as Chief Medical Officer, Pulmonology
Qure. ai has appointed Dr Javier J Zulueta, previously Professor of Medicine at the Icahn School of Medicine at Mount Sinai in New York and Pulmonary Division Chief at Mount Sinai Morningside Hospital, to the new position of Chief Medical Officer, Pulmonology. The role
will dovetail his deep clinical insight to the ongoing research & development in lung health AI and digital health care coordination solutions to bolster Qure. ai’ s pace of business expansion in the USA and Europe. Dr Zulueta brings more than three decades of experience as a physician, scientist, academician and pioneer in interventional pulmonology, lung cancer screening and pulmonary nodule / disease management.
Nilesh Shah joins Illumina as Head of Region, AMEA
Illumina Inc. has announced the appointment of Nilesh Shah as Head of Region, AMEA, effective immediately. Nilesh brings over 25 years of leadership experience in the medical technology and life sciences industries, having held senior roles at Johnson & Johnson, GE Healthcare and most recently, West Pharmaceutical Services. At West, he served as Vice President & General Manager, Emerging Markets, where he led commercial, operational, and manufacturing strategies spanning Asia-Pacific and Latin America. During his tenure, he drove regional transformation, enhanced customer
48
BioVoiceNews | September 2025